Pulmonx Corporation LUNG
1.91
0.01
0.53%
as of 25 Sep
- Market cap
- $81.6M
- P/E
- 0.0×
Follow LUNG
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 3.33 | 3.33 | 21.48 | 23.93 | 5.18 | 7.02 | 3.17 | 0.99 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (18.98) | (18.98) | (96.80) | (108.17) | (28.34) | (57.08) | (39.46) | (12.69) |
P/B ratio |
— | 0.00 | 0.00 | 3.11 | 6.00 | 1.80 | 4.08 | 3.09 | 1.66 |
Price to Tangible BV |
— | 0.00 | 0.00 | 3.15 | 6.08 | 1.83 | 4.16 | 3.18 | 1.74 |
EV/Sales |
— | 3.58 | 3.58 | 14.98 | 20.61 | 2.87 | 5.86 | 2.40 | 0.63 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (4.44) | (4.44) | (16.00) | (24.11) | (3.41) | (10.69) | (6.37) | (1.76) |
EV/FCF |
— | (4.36) | (4.36) | (15.54) | (22.15) | (3.31) | (10.47) | (6.09) | (1.74) |
Quick Ratio |
— | 0.88 | 2.39 | 18.84 | 10.65 | 8.11 | 5.59 | 4.70 | 4.09 |
Current Ratio |
— | 1.40 | 2.90 | 19.96 | 11.85 | 9.14 | 6.50 | 5.58 | 5.07 |
Net Debt/EBITDA |
— | (2.00) | 0.74 | 6.88 | 3.47 | 2.17 | 1.31 | 1.12 | 0.62 |
Debt/Assets |
0.00% | 223.84% | 28.79% | 7.22% | 8.34% | 8.94% | 20.95% | 22.83% | 28.61% |
Debt/Equity |
— | (1.25) | 0.86 | 0.08 | 0.10 | 0.11 | 0.31 | 0.43 | 0.68 |
Asset Turnover |
— | 2.66 | 0.95 | 0.21 | 0.19 | 0.25 | 0.37 | 0.49 | 0.62 |
Operating CF/Net income |
— | 1.00 | 1.00 | 0.95 | 0.85 | 0.77 | 0.62 | 0.56 | 0.60 |
Capex/Depreciation |
— | (0.98) | (2.17) | (0.64) | (3.56) | (0.97) | (1.41) | 20.38 | (0.62) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 10.42% | 11.67% | (166.33%) | (23.21%) | (33.94%) | (44.68%) | (55.25%) | (77.19%) | |
| — | (246.17%) | (60.41%) | (20.32%) | (19.51%) | (27.48%) | (32.76%) | (33.11%) | (36.97%) | |
ROIC |
— | (349.72%) | (221.87%) | (150.98%) | (90.74%) | (122.32%) | (101.28%) | (169.73%) | (158.98%) |
Return on Tangible Assets |
— | (511.74%) | (74.44%) | (13.49%) | (24.92%) | (37.98%) | (46.34%) | (49.16%) | (64.41%) |
Average Days of Receivables |
— | 53.83 | 61.71 | 47.15 | 49.47 | 59.02 | 64.34 | 57.15 | 48.69 |
Research and Development Expense of Revenue |
— | 34.95% | 18.56% | 22.79% | 26.98% | 28.69% | 26.33% | 20.97% | 21.54% |
Selling, General and Administrative Expense of Revenue |
— | 101.71% | 104.93% | 140.76% | 144.31% | 154.87% | 137.76% | 121.90% | 111.95% |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Share Based Compensation of Revenue |
— | 1.83% | 1.12% | 9.77% | 21.75% | 30.65% | 32.18% | 27.40% | 23.46% |
Graham Net Nets |
— | (2.01) | (2.01) | 0.30 | 0.14 | 0.47 | 0.19 | 0.22 | 0.29 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (29.03%) | (29.03%) | (16.74%) | (4.08%) | (21.23%) | (12.60%) | (21.21%) | (60.18%) |
Free Cash Flow Yield |
— | (24.65%) | (24.65%) | (4.49%) | (3.89%) | (16.70%) | (7.97%) | (12.42%) | (36.51%) |
Revenue per Share |
— | 11.94 | 18.35 | 3.21 | 1.34 | 1.45 | 1.81 | 2.14 | 2.22 |
Operating CF per Share |
— | (10.98) | (11.69) | (3.01) | (1.15) | (1.22) | (0.99) | (0.81) | (0.80) |
Capex per Share |
— | (0.18) | (0.41) | (0.09) | (0.10) | (0.04) | (0.02) | (0.04) | (0.01) |
Free Cash Flow per Share |
— | (11.16) | (12.10) | (3.10) | (1.25) | (1.25) | (1.01) | (0.84) | (0.81) |
Cash per Share |
— | 2.46 | 15.96 | 22.76 | 4.99 | 3.81 | 3.09 | 2.60 | 1.72 |
Shareholders Equity per Share |
— | (15.99) | 10.11 | 22.20 | 5.35 | 4.15 | 3.12 | 2.19 | 1.33 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (15.99) | 10.11 | 22.20 | 5.35 | 4.15 | 3.12 | 2.19 | 1.33 |
Free Cash Flow |
— | (18.69) | (21.48) | (31.54) | (45.06) | (46.40) | (38.42) | (32.98) | (32.83) |
Working Capital |
— | 3.24 | 26.91 | 237.46 | 190.45 | 150.46 | 127.27 | 111.81 | 81.63 |
Capital Expenditures |
— | (0.30) | (0.72) | (0.91) | (3.67) | (1.32) | (0.81) | (1.45) | (0.45) |
Net Current Asset Value |
— | (30.50) | 5.50 | 212.42 | 166.07 | 129.28 | 90.96 | 59.21 | 26.51 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.02 | 0.02 | 0.03 | 0.08 | 0.02 | 0.01 | 0.02 | 0.01 |
Net Profit Margin |
— | (92.38%) | (63.52%) | (98.47%) | (100.51%) | (109.80%) | (88.60%) | (67.30%) | (59.67%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.82 | 0.37 | 0.96 | 0.21 | 0.29 | 0.14 | (0.02) | 0.33 |
Cash ROIC |
— | (171.59%) | (35.11%) | (6.73%) | (11.75%) | (15.92%) | (15.26%) | (15.33%) | (21.47%) |
Accounts Receivable Turnover |
— | 4.25 | 7.70 | 6.72 | 8.97 | 7.04 | 6.61 | 6.64 | 7.18 |
Accounts Payable Turnover |
— | 3.89 | 5.13 | 5.55 | 8.37 | 8.26 | 11.01 | 8.18 | 6.04 |
Inventory Turnover |
— | 1.73 | 2.28 | 1.41 | 0.95 | 0.89 | 1.15 | 1.29 | 1.43 |
Average Days of Payables |
— | 60.96 | 96.12 | 46.59 | 45.16 | 46.51 | 30.49 | 64.11 | 61.02 |
Days of Inventory on Hand |
— | 157.01 | 201.20 | 339.99 | 464.89 | 385.29 | 340.97 | 283.37 | 247.60 |
Average Receivables |
— | 4.71 | 4.23 | 4.87 | 5.40 | 7.62 | 10.39 | 12.61 | 12.60 |
Average Payables |
— | 1.99 | 1.99 | 2.08 | 1.53 | 1.67 | 1.63 | 2.66 | 3.87 |
Average Inventory |
— | 4.47 | 4.47 | 8.18 | 13.51 | 15.42 | 15.65 | 16.83 | 16.38 |
Average Assets |
— | 7.51 | 34.27 | 158.62 | 249.44 | 214.42 | 185.73 | 170.32 | 146.07 |
Average Common Equity |
— | (177.35) | (177.35) | 19.38 | 209.69 | 173.62 | 136.16 | 102.06 | 69.96 |
Columns are period end dates